BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pilotto A, Franceschi M, Leandro G, Scarcelli C, D’Ambrosio LP, Paris F, Annese V, Seripa D, Andriulli A, Di Mario F. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. World J Gastroenterol 2007; 13(33): 4467-4472 [PMID: 17724802 DOI: 10.3748/wjg.v13.i33.4467]
URL: https://www.wjgnet.com/1007-9327/full/v13/i33/4467.htm
Number Citing Articles
1
Motoyasu Kusano, Shikou Kuribayashi, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Atsuto Nagoshi, Hiroaki Zai, Masatomo Mori. A Review of the Management of Gastric Acid-Related Diseases: Focus on RabeprazoleClinical Medicine. Gastroenterology 2011; 4: CGast.S5133 doi: 10.4137/CGast.S5133
2
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problemTerapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
3
F.M. Huerta-Iga, J.L. Tamayo-de la Cuesta, A. Noble-Lugo, J.M. Remes-Troche, M.A. Valdovinos-Díaz, R.I. Carmona-Sánchez. Consenso mexicano de enfermedad por relujo gastroesofágico. Parte IRevista de Gastroenterología de México 2012; 77(4): 193 doi: 10.1016/j.rgmx.2012.10.002
4
Cátia Santos-Pereira, María T. Andrés, José F. Fierro, Lígia R. Rodrigues, Manuela Côrte-Real. A review on lactoferrin as a proton pump inhibitorInternational Journal of Biological Macromolecules 2022; 202: 309 doi: 10.1016/j.ijbiomac.2022.01.075
5
Claudine M. Baldwin, Susan J. Keam. RabeprazoleDrugs 2009; 69(10): 1373 doi: 10.2165/00003495-200969100-00007
6
Boris D. Starostin. Contemporary Approaches to the Treatment of Gastroesophageal Reflux DiseaseRussian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 7 doi: 10.22416/1382-4376-2019-29-1-7-16
7
A. Pilotto, S. Maggi, M. Noale, M. Franceschi, G. Parisi, G. Crepaldi. Development and Validation of a New Questionnaire for the Evaluation of Upper Gastrointestinal Symptoms in the Elderly Population: A Multicenter StudyThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2010; (2): 174 doi: 10.1093/gerona/glp073
8
X. M. Xia, H. Wang. Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-AnalysisGastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/327571
9
Marilisa Franceschi, Francesco Di Mario, Gioacchino Leandro, Stefania Maggi, Alberto Pilotto. Acid-related disorders in the elderlyBest Practice & Research Clinical Gastroenterology 2009; 23(6): 839 doi: 10.1016/j.bpg.2009.10.004
10
Shaojun Shi, Ulrich Klotz. Proton pump inhibitors: an update of their clinical use and pharmacokineticsEuropean Journal of Clinical Pharmacology 2008; 64(10): 935 doi: 10.1007/s00228-008-0538-y
11
Vandana Boparai, Jaishree Rajagopalan, George Triadafilopoulos. Guide to the Use of Proton Pump Inhibitors in Adult PatientsDrugs 2008; 68(7): 925 doi: 10.2165/00003495-200868070-00004
12
Chao Zhang, Joey S. W. Kwong, Rui-Xia Yuan, Hao Chen, Chang Xu, Yi-Pin Wang, Gong-Li Yang, Jin-Zhu Yan, Le Peng, Xian-Tao Zeng, Hong Weng, Jie Luo, Yu-Ming Niu. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE systemScientific Reports 2017; 7(1) doi: 10.1038/srep41021
13
E. Márquez-Contreras, V. Gil, J. López, M. J. Plazas, J. Heras, J. Galván, J. Porcel. Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary careCurrent Medical Research and Opinion 2008; 24(2): 569 doi: 10.1185/030079908X261104
14
Kazuyoshi Hirota, Atsushi Imai, Mihoko Kudo, Hiroshi Hashimoto, Tetsuya Kushikata. Efficacy of a single 24‐hour pre‐anesthetic dose of proton pump inhibitorsJournal of Gastroenterology and Hepatology 2009; 24(7): 1244 doi: 10.1111/j.1440-1746.2009.05850.x
15
Naoki Chiba, M Brian Fennerty. Evidence‐Based Gastroenterology and Hepatology2010; : 17 doi: 10.1002/9781444314403.ch2
16
Viktoriia Prikhodko, Diana Moreva. Features of the Course and Treatment of Hypertension in Combination with Chronicis Chemic Heart Disease in Patients with Gastroesophagel Refluxdisease. Role of Proton Pump Inhibitors Test in the Diagnosis and Treatment of Different Forms of GERDFamily medicine 2016; (4): 75 doi: 10.30841/2307-5112.4.2016.248527
17
Stefano Pallotta, Fabio Pace, Silvia Marelli. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related diseaseExpert Review of Gastroenterology & Hepatology 2008; 2(4): 509 doi: 10.1586/17474124.2.4.509
18
Muhammad Rizwan Umer, Wendy E. Mejia Crespo, Sana Dugan, Hamna Javed, Muhammad Suleman, Muhammad Waqas Afzal, Hassan Mumtaz, Muhammad Saqib, Haris Mumtaz Malik, Muhammad Iftikhar. Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trialAnnals of Medicine & Surgery 2023; 85(10): 4866 doi: 10.1097/MS9.0000000000001235